Related Experiment Video
Updated: Aug 1, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Transnasal butorphanol is effective for postoperative pain relief in children undergoing myringotomy
R E Bennie1, L A Boehringer, S F Dierdorf
1Department of Anesthesia, Indiana University School of Medicine, Indianapolis 46202-5200, USA. rbennie@iupui.edu
Insights
Transnasal butorphanol at 25 mcg/kg effectively managed pain after bilateral myringotomy and tube placement (BMT) in children. This route offers an alternative for postoperative pain relief when IV access is not feasible.
Area of Science:
- Anesthesiology
- Pediatric Pain Management
- Pharmacology
Background:
- Over 70% of children need pain relief after bilateral myringotomy and tube placement (BMT).
- Anesthesia for BMT often uses face masks, precluding intravenous catheter use for analgesia.
- Transnasal butorphanol is a potential alternative for postoperative pain management in pediatric patients.
Purpose of the Study:
- To evaluate the effectiveness of transnasal butorphanol for managing postoperative pain in children undergoing BMT.
- To determine the optimal dosage of transnasal butorphanol for pediatric pain relief post-BMT.
Main Methods:
- A double-blinded, placebo-controlled study involving 60 pediatric patients (ASA physical status 1 or 2, aged ≥6 months) undergoing elective BMT.
- Randomization to receive transnasal placebo or butorphanol at doses of 5, 15, or 25 mcg/kg after anesthesia induction.
- Postoperative pain assessment using the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) at multiple time points.
Main Results:
- The 25 mcg/kg transnasal butorphanol group showed significantly lower CHEOPS scores compared to the placebo group.
- Significantly fewer children in the 25 mcg/kg group required rescue analgesia (1 vs. 8, P = 0.02).
Conclusions:
- Transnasal butorphanol, administered at 25 mcg/kg post-anesthesia induction, provides effective postoperative pain relief for children undergoing BMT.
- This non-intravenous route is a viable option for analgesia in pediatric BMT patients.
Background:
More than 70% of children require analgesics after bilateral myringotomy and tube placement (BMT). Because anesthesia for BMT is generally provided by face mask without placement of an intravenous catheter, an alternative route for analgesia administration is needed. Transnasal butorphanol is effective in relieving postoperative pain in adults and children. The effectiveness of transnasal butorphanol for postoperative pain management in children undergoing BMT was studied.
Methods:
This double-blinded, placebo-controlled study compared the postoperative analgesic effects of transnasal butorphanol administered after the induction of anesthesia. Sixty children classified as American Society of Anesthesiologists physical status 1 or 2 who were aged 6 months or older and scheduled for elective BMT were randomized to receive transnasal placebo or 5, 15, or 25 microg/kg butorphanol. Postoperative pain was assessed using the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) on arrival in the postanesthesia care unit and at 5, 10, 15, 30, 45, and 60 min.
Results:
The CHEOP scores were significantly less in the 25 microg/kg transnasal butorphanol group compared with controls. Significantly fewer children received rescue analgesia in the 25 microg/kg transnasal butorphanol group compared with controls (n = 1 and 8, respectively; P = 0.02).
Conclusions:
Transnasal butorphanol given in a dose of 25 microg/kg after induction of anesthesia provided adequate postoperative pain relief in children undergoing BMT.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview

